Aurobindo Pharma Share Price Gains As USFDA Concludes Inspection At Subsidiary Lannett's Unit

<iframe
  src="https://hindustansphere.com/embed/cluster/3e5b7b346866a54e053e563f01794c122db0ca36"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Aurobindo Pharma Share Price Gains As USFDA Concludes Inspection At Subsidiary Lannett's Unit"></iframe>